Cleave Biosciences Lands $10,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b1a01177-c3fe-40a7-a877-8f56766150b1&Preview=1 - Date
4/9/2013 - Company Name
Cleave Biosciences - Mailing Address
866 Malcolm Burlingame, CA 94010 - Company Description
The big idea at Cleave is to develop small-molecule chemical compounds that will interact with certain protein pathways that get thrown out of whack in patients with cancer. - Website
http://www.cleavebio.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Series A - Proceeds Purposes
Cleave will use the funds to move its lead program into clinical trials and advance its second discovery program. - M&A Terms
- Venture Investor
New Enterprise Associates
